These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4166834)

  • 1. New laws on control of drugs?
    Lancet; 1967 Sep; 2(7516):601-2. PubMed ID: 4166834
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of drugs.
    Br Med J; 1967 Sep; 3(5567):689-90. PubMed ID: 6038356
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE RISK OF POISONING IN THE USE OF DRUGS].
    BARNES JM
    Sven Farm Tidskr; 1963 Sep; 67():739-47. PubMed ID: 14087146
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Control of advertising.
    Br Dent J; 1975 Aug; 139(4):123-4. PubMed ID: 1057430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ethics of medical advertising].
    de Oliveira E
    Hospital (Rio J); 1969 Oct; 76(4):1385-94. PubMed ID: 5308117
    [No Abstract]   [Full Text] [Related]  

  • 6. How does legislation protect the public from poisoning?
    Priest L
    Adv Sci; 1967 Feb; 23(116):511-7. PubMed ID: 6044857
    [No Abstract]   [Full Text] [Related]  

  • 7. [The report on drugs].
    Andersen V
    Ugeskr Laeger; 1973 Jun; 135(25):1349-52. PubMed ID: 4757130
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prohibited physician advertising and allowable information].
    Broglie MG
    Z Gesamte Inn Med; 1991 Apr; 46(5):172-3. PubMed ID: 2068848
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicines (Advertisement and Sale) (Amendment) Act, 1968.
    Leng GA
    Singapore Med J; 1969 Mar; 10(1):1. PubMed ID: 5803556
    [No Abstract]   [Full Text] [Related]  

  • 10. General practitioners' views of information about drugs.
    Eaton G; Parish P
    J R Coll Gen Pract; 1976; 26 Suppl 1(Suppl 1):64-8. PubMed ID: 1011222
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic evaluation of pharmaceuticals.
    Massam D
    Pharmacoeconomics; 1992 Mar; 1(3):217. PubMed ID: 10172056
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of references in drug advertisements.
    Stimson GV
    J R Coll Gen Pract; 1976; 26 Suppl 1(Suppl 1):76-80. PubMed ID: 1011224
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs.
    Hunter AR
    Lancet; 1975 Sep; 2(7933):493-4. PubMed ID: 51296
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct to consumer advertising of prescription drugs. An idea whose time should not come.
    Hoffman JR; Wilkes M
    BMJ; 1999 May; 318(7194):1301-2. PubMed ID: 10323794
    [No Abstract]   [Full Text] [Related]  

  • 15. INFORMED CONSENT: SHOULD NEW DRUGS BEGET NEW LAWS?
    SCHROEDER OC
    Postgrad Med; 1963 Dec; 34():A26-A31. PubMed ID: 14103037
    [No Abstract]   [Full Text] [Related]  

  • 16. Backchat. Money well spent?
    Faugier J
    Nurs Times; 1985 Jul 10-16; 81(28):56. PubMed ID: 3848853
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudonutrition and the Medicines Act.
    Hanssen M
    Lancet; 1990 May; 335(8699):1223-4. PubMed ID: 1971066
    [No Abstract]   [Full Text] [Related]  

  • 19. [A contribution to the development of advertising in pharmacy II. Historical development of regulation of advertising of medicinal products].
    Vranová V
    Ceska Slov Farm; 2012 Oct; 61(5):240-3. PubMed ID: 23256658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASPECTS OF DEVELOPMENT OF NEW DRUGS.
    KLUMPP T
    IMJ Ill Med J; 1963 Oct; 124():307-13. PubMed ID: 14067809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.